glp-1 drug shortages Out of Shortage, Into Controversy: The Fight Over Compounding GLP-1 Drugs: The Science and
Description
As noted previously, currently we do not have any large clinical trials for the treatment of HF or CKD in patients with or without T2D using GLP-1RA
PMID 24112036
[DOI] [PubMed] [Google Scholar] [26].Cesta CE, Rotem R, Bateman BT, et al
Meanwhile, Eli Lilly is juggling lawsuits filed by Trulicity patients who allege they suffered severe, unexpected complications after taking Trulicity
The shift supports a move toward beverages that support emotional and metabolic health
